Skip to main content
SpringerLink
Log in

Wearable Cardioverter-Defibrillators

  • Chapter
  • First Online:
Clinical Controversies in Device Therapy for Cardiac Arrhythmias

  • 255 Accesses

Abstract

The wearable cardioverter-defibrillator (WCD), manufactured and marketed by ZOLL® Corporation, is a noninvasive wearable device used for protection against sudden cardiac death in patients indicated for an implantable cardioverter-defibrillator (ICD) who are unable to receive an ICD due to various transient conditions, such as infections, or during blanking phases of further risk stratification, such as those following acute myocardial infarction or coronary revascularization.

In this chapter, we review technical aspects of WCD function as well as the design and results of clinical trials that evaluated its use over the past several years. Special attention is spent assessing the strengths and limitations of published data in support or against use of the WCD in various patient populations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Adler A, Halkin A, Viskin S. Wearable cardioverter-defibrillators. Circulation. 2013;127:854–60.

    Article  Google Scholar 

  2. http://lifevest.zoll.com/.

  3. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC Jr, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, American College of Cardiology/American Heart Association Task Force, European Society of Cardiology Committee for Practice Guidelines, European Heart Rhythm Association, Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114:e385–484.

    Article  Google Scholar 

  4. Chung MK, Szymkiewicz SJ, Shao M, et al. Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival. J Am Coll Cardiol. 2010;56:194–203.

    Article  Google Scholar 

  5. Klein HU, Meltendorf U, Reek S, et al. Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD). Pacing Clin Electrophysiol. 2010;33:353–567.

    Article  Google Scholar 

  6. Lee BK, Olgin JE. Role of wearable and automatic external defibrillators in improving survival in patients at risk for sudden cardiac death. Curr Treat Options Cardiovasc Med. 2009;11:360–5.

    Article  Google Scholar 

  7. http://www.acc.org/latest-in-cardiology/clinical-trials/2018/03/09/08/06/vest.

  8. Feldman AM, Klein H, Tchou P, Murali S, Hall WJ, Mancini D, Boehmer J, Harvey M, Heilman MS, Szymkiewicz SJ, Moss AJ, WEARIT investigators and coordinators, BIROAD Investigators and Coordinators. Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD. Pacing Clin Electrophysiol. 2004;27:4–9.

    Article  Google Scholar 

  9. https://en.wikipedia.org/wiki/Wearable_cardioverter_defibrillator.

  10. Collins KK, Silva JN, Rhee EK, Schaffer MS. Use of a wearable automated defibrillator in children compared to young adults. Pacing Clin Electrophysiol. 2010;33:1119–24.

    Article  Google Scholar 

  11. https://www.accessdata.fda.gov/cdrh_docs/pdf/P010030S056d.pdf.

  12. https://lifevest.mymarketingbench.com/images/1/21-90020000/20C0010.pdf.

  13. http://lifevest.zoll.com/medical-professionals/lifevest-network/.

  14. https://lifevest.zoll.com/sites/default/files/LifeVestNetworkCaseAFib.pdf.

  15. Rodriguez Y, Althouse AD, Adelstein EC, et al. Characteristics and outcomes of concurrently diagnosed new rapid atrial fibrillation or flutter and new reduced ejection fraction. Pacing Clin Electrophysiol. 2016;39:1394–403.

    Article  Google Scholar 

  16. Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2018;72:1677–749.

    Google Scholar 

  17. Klein HU, Goldenberg I, Moss AJ. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator. Eur Heart J. 2013;34:2230–42.

    Article  Google Scholar 

  18. Solomon SD, Zelenkofske S, McMurray JJ, et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med. 2005;352:2581–8.

    Article  CAS  Google Scholar 

  19. Steinbeck G, Andresen D, Seidl K, et al. Defibrillator implantation early after myocardial infarction. N Engl J Med. 2009;361:1427–36.

    Article  CAS  Google Scholar 

  20. Hohnloser SH, Kuck KH, Dorian P, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481–8.

    Article  CAS  Google Scholar 

  21. Epstein AE, Abraham WT, Bianco NR, et al. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction. J Am Coll Cardiol. 2013;62:2000–7.

    Article  Google Scholar 

  22. Kutyifa V, Moss AJ, Klein H, et al. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry). Circulation. 2015;132:1613–9.

    Article  Google Scholar 

  23. Singh M, Wang NC, Jain S, Voigt AH, Saba S, Adelstein EC. Utility of the wearable cardioverter-defibrillator in patients with newly diagnosed cardiomyopathy: a decade-long single-center experience. J Am Coll Cardiol. 2015;66:2607–13.

    Article  Google Scholar 

  24. Vest Prevention of Early Sudden Death Trial and VEST Registry (VEST). ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01446965.

  25. Allen LA, Adler ED, Bayes-Genis A, et al. When the VEST does not fit: representations of trial results deviating from rigorous data interpretation. Circ Heart Fail. 2018;11:e005116.

    Article  Google Scholar 

  26. van Welsenes GH, van Rees JB, Borleffs CJ, et al. Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients. Europace. 2011;13:389–94.

    Article  Google Scholar 

  27. Van Gelder IC, Groenveld HF, Crijns HJ, Tuininga YS, Tijssen JG, Alings AM, Hillege HL, Bergsma-Kadijk JA, Cornel JH, Kamp O, Tukkie R, Bosker HA, Van Veldhuisen DJ, Van den Berg MP, RACE II Investigators. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med. 2010;362:1363–73.

    Article  Google Scholar 

  28. Ladejobi A, Pasupula DK, Adhikari S, et al. Implantable defibrillator therapy in cardiac arrest survivors with a reversible cause. Circ Arrhythm Electrophysiol. 2081;11:e0055940.

    Google Scholar 

Download references

Conflicts of Interest

The are no conflicts of interest for any of the authors regarding the subject matter of this chapter.

Author information

Authors and Affiliations

  1. Albany Medical College, Albany, NY, USA

    Evan Adelstein

  2. Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

    Norman Wang & Samir Saba

Authors
  1. Evan Adelstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Norman Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Samir Saba
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Samir Saba .

Editor information

Editors and Affiliations

  1. University of Rochester School of Medicine & Dentistry/Hackensack Meridian, School of Medicine at Seton Hall, University/Summit Medical Group, Short Hills, NJ, USA

    Jonathan S. Steinberg

  2. Electrophysiology Section, Cardiovascular Division, Univeristy of Pennsylvania, and the Cardiology Division, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA

    Andrew E. Epstein

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Adelstein, E., Wang, N., Saba, S. (2019). Wearable Cardioverter-Defibrillators. In: Steinberg, J., Epstein, A. (eds) Clinical Controversies in Device Therapy for Cardiac Arrhythmias . Springer, Cham. https://doi.org/10.1007/978-3-030-22882-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-22882-8_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-22881-1

  • Online ISBN: 978-3-030-22882-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation